The Effectiveness of Antiviral Treatment in Severe COVID-19 Patients in Wuhan, China: A Multicenter Study.

Author: Xian Long ZHOU ¹ ; Guo Yong DING ² ; Lu Yu YANG ³ ; Rui Ning LIU ¹ ; Hai Feng HOU ² ; Ping WANG ² ; Min MA ⁴ ; Zhuan Zhuan HU ⁴ ; Lei HUANG ⁴ ; Xi Zhu XU ² ; Quan HU ⁵ ; Yan ZHAO ^{6
,

7} ; Wei Jia XING ² ; Zhi Gang ZHAO ^{6
,

7}
Author Information

1. Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China.
2. School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an 271016, Shandong, China.
3. Intensive Care Unit, Wuhan Third Hospital, Wuhan 430060, Hubei, China.
4. Intensive Care Unit, Huazhong University of Science and Technology Union Jiangbei Hospital, Wuhan 430100, Hubei, China.
5. Intensive Care Unit, The first people's Hospital of Jiangxia District, Wuhan 430200, Hubei, China.
6. Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China
7. Hubei Clinical Research Center for Emergency and Resuscitation, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China.
Publication Type:Research Support, Non-U.S. Gov't
MeSH: Aged; Antiviral Agents/therapeutic use*; COVID-19/drug therapy*; China/epidemiology*; Cohort Studies; Female; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Patient Acuity; SARS-CoV-2; Treatment Outcome
From: Biomedical and Environmental Sciences 2022;35(1):58-63
CountryChina
Language:English